The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Head and Neck Neoplasms

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Head and Neck Neoplasms


Psychiatry related information on Head and Neck Neoplasms


High impact information on Head and Neck Neoplasms


Chemical compound and disease context of Head and Neck Neoplasms


Biological context of Head and Neck Neoplasms


Anatomical context of Head and Neck Neoplasms


Gene context of Head and Neck Neoplasms


Analytical, diagnostic and therapeutic context of Head and Neck Neoplasms


  1. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups. van Zandwijk, N., Dalesio, O., Pastorino, U., de Vries, N., van Tinteren, H. J. Natl. Cancer Inst. (2000) [Pubmed]
  2. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. Argiris, A., Li, Y., Murphy, B.A., Langer, C.J., Forastiere, A.A. J. Clin. Oncol. (2004) [Pubmed]
  3. Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. Cullen, K.J., Newkirk, K.A., Schumaker, L.M., Aldosari, N., Rone, J.D., Haddad, B.R. Cancer Res. (2003) [Pubmed]
  4. A multicenter, randomized, double-blind, placebo-controlled, dose-titration study of oral pilocarpine for treatment of radiation-induced xerostomia in head and neck cancer patients. LeVeque, F.G., Montgomery, M., Potter, D., Zimmer, M.B., Rieke, J.W., Steiger, B.W., Gallagher, S.C., Muscoplat, C.C. J. Clin. Oncol. (1993) [Pubmed]
  5. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system. El-Sayed, S., Nabid, A., Shelley, W., Hay, J., Balogh, J., Gelinas, M., MacKenzie, R., Read, N., Berthelet, E., Lau, H., Epstein, J., Delvecchio, P., Ganguly, P.K., Wong, F., Burns, P., Tu, D., Pater, J. J. Clin. Oncol. (2002) [Pubmed]
  6. Manifest Anxiety Scale for evaluation of effects of granisetron in chemotherapy with CDDP and 5FU for head and neck cancer. Fujii, M., Ohno, Y., Tokumaru, Y., Imanishi, Y., Kanke, M., Tomita, T., Kanzaki, J. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. (2001) [Pubmed]
  7. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. Browman, G.P., Wong, G., Hodson, I., Sathya, J., Russell, R., McAlpine, L., Skingley, P., Levine, M.N. N. Engl. J. Med. (1993) [Pubmed]
  8. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. Johnston, P.G., Mick, R., Recant, W., Behan, K.A., Dolan, M.E., Ratain, M.J., Beckmann, E., Weichselbaum, R.R., Allegra, C.J., Vokes, E.E. J. Natl. Cancer Inst. (1997) [Pubmed]
  9. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement. Epstein, A.H., Lebovics, R.S., Goffman, T., Teague, D., Fuetsch, E.S., Glatstein, E., Okunieff, P., Cook, J.A. J. Natl. Cancer Inst. (1994) [Pubmed]
  10. Overview of combined modality therapies for head and neck cancer. Dimery, I.W., Hong, W.K. J. Natl. Cancer Inst. (1993) [Pubmed]
  11. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. Vokes, E.E., Weichselbaum, R.R., Mick, R., McEvilly, J.M., Haraf, D.J., Panje, W.R. J. Natl. Cancer Inst. (1992) [Pubmed]
  12. Controlled trial of methotrexate and Bacillus Calmette-Guérin therapy for advanced head and neck cancer. Papac, R., Minor, D.R., Rudnick, S., Solomon, L.R., Capizzi, R.L. Cancer Res. (1978) [Pubmed]
  13. Very-high-dose cisplatin with bleomycin infusion as initial treatment of advanced head and neck cancer. Haines, I., Bosl, G., Pfister, D., Spiro, R., Gerold, F., Sessions, R., Shah, J., Strong, E., Vikram, B., Harrison, L. J. Clin. Oncol. (1987) [Pubmed]
  14. A phase I-II trial of carboplatin and 5-fluorouracil combination chemotherapy in advanced carcinoma of the head and neck. Forastiere, A.A., Natale, R.B., Takasugi, B.J., Goren, M.P., Vogel, W.C., Kudla-Hatch, V. J. Clin. Oncol. (1987) [Pubmed]
  15. 2-Deoxy-D-glucose combined with cisplatin enhances cytotoxicity via metabolic oxidative stress in human head and neck cancer cells. Simons, A.L., Ahmad, I.M., Mattson, D.M., Dornfeld, K.J., Spitz, D.R. Cancer Res. (2007) [Pubmed]
  16. Targeted inhibition of Stat3 with a decoy oligonucleotide abrogates head and neck cancer cell growth. Leong, P.L., Andrews, G.A., Johnson, D.E., Dyer, K.F., Xi, S., Mai, J.C., Robbins, P.D., Gadiparthi, S., Burke, N.A., Watkins, S.F., Grandis, J.R. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  17. Frequent abnormalities of FHIT, a candidate tumor suppressor gene, in head and neck cancer cell lines. Mao, L., Fan, Y.H., Lotan, R., Hong, W.K. Cancer Res. (1996) [Pubmed]
  18. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells. Garrigue-Antar, L., Muñoz-Antonia, T., Antonia, S.J., Gesmonde, J., Vellucci, V.F., Reiss, M. Cancer Res. (1995) [Pubmed]
  19. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Xi, S., Zhang, Q., Gooding, W.E., Smithgall, T.E., Grandis, J.R. Cancer Res. (2003) [Pubmed]
  20. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells. Kawakami, K., Leland, P., Puri, R.K. Cancer Res. (2000) [Pubmed]
  21. Elevated levels of transforming growth factor alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Grandis, J.R., Tweardy, D.J. Cancer Res. (1993) [Pubmed]
  22. Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. Brockstein, B., Haraf, D.J., Stenson, K., Fasanmade, A., Stupp, R., Glisson, B., Lippman, S.M., Ratain, M.J., Sulzen, L., Klepsch, A., Weichselbaum, R.R., Vokes, E.E. J. Clin. Oncol. (1998) [Pubmed]
  23. Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells. Rabinowich, H., Vitolo, D., Altarac, S., Herberman, R.B., Whiteside, T.L. J. Immunol. (1992) [Pubmed]
  24. Allelic imbalance on chromosome 2q and alterations of the caspase 8 gene in neuroblastoma. Takita, J., Yang, H.W., Chen, Y.Y., Hanada, R., Yamamoto, K., Teitz, T., Kidd, V., Hayashi, Y. Oncogene (2001) [Pubmed]
  25. Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade. Yigitbasi, O.G., Younes, M.N., Doan, D., Jasser, S.A., Schiff, B.A., Bucana, C.D., Bekele, B.N., Fidler, I.J., Myers, J.N. Cancer Res. (2004) [Pubmed]
  26. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Rosas, S.L., Koch, W., da Costa Carvalho, M.G., Wu, L., Califano, J., Westra, W., Jen, J., Sidransky, D. Cancer Res. (2001) [Pubmed]
  27. Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors. Zweifel, B.S., Davis, T.W., Ornberg, R.L., Masferrer, J.L. Cancer Res. (2002) [Pubmed]
  28. SRC family kinases mediate epidermal growth factor receptor ligand cleavage, proliferation, and invasion of head and neck cancer cells. Zhang, Q., Thomas, S.M., Xi, S., Smithgall, T.E., Siegfried, J.M., Kamens, J., Gooding, W.E., Grandis, J.R. Cancer Res. (2004) [Pubmed]
  29. Combination gene therapy for oral cancer in a murine model. O'Malley, B.W., Cope, K.A., Chen, S.H., Li, D., Schwarta, M.R., Woo, S.L. Cancer Res. (1996) [Pubmed]
  30. Carcinoembryonic antigen as a target for specific antitumor immunotherapy of head and neck cancer. Kass, E.S., Greiner, J.W., Kantor, J.A., Tsang, K.Y., Guadagni, F., Chen, Z., Clark, B., De Pascalis, R., Schlom, J., Van Waes, C. Cancer Res. (2002) [Pubmed]
  31. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer. Kawakami, K., Kawakami, M., Joshi, B.H., Puri, R.K. Cancer Res. (2001) [Pubmed]
  32. Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer. Kaanders, J.H., Wijffels, K.I., Marres, H.A., Ljungkvist, A.S., Pop, L.A., van den Hoogen, F.J., de Wilde, P.C., Bussink, J., Raleigh, J.A., van der Kogel, A.J. Cancer Res. (2002) [Pubmed]
  33. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab')2. van Dongen, G.A., Leverstein, H., Roos, J.C., Quak, J.J., van den Brekel, M.W., van Lingen, A., Martens, H.J., Castelijns, J.A., Visser, G.W., Meijer, C.J. Cancer Res. (1992) [Pubmed]
WikiGenes - Universities